A prospective observational study of adoptive immunotherapy for cancer using Zoledronate-Activated Killer (ZAK) Cells - An analysis for patients with incurable pancreatic cancer

Yoshiyuki Yamaguchi, Yousuke Katata, Makoto Okawaki, Akira Sawaki, Masahiro Yamamura

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A prospective observational study of adoptive immunotherapy for cancer using Zoledronate-Activated Killer (ZAK) Cells - An analysis for patients with incurable pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences